Literature DB >> 33793459

Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic - United States, August 2020-February 2021.

Anjel Vahratian1, Stephen J Blumberg1, Emily P Terlizzi1, Jeannine S Schiller1.   

Abstract

The spread of disease and increase in deaths during large outbreaks of transmissible diseases is often associated with fear and grief (1). Social restrictions, limits on operating nonessential businesses, and other measures to reduce pandemic-related mortality and morbidity can lead to isolation and unemployment or underemployment, further increasing the risk for mental health problems (2). To rapidly monitor changes in mental health status and access to care during the COVID-19 pandemic, CDC partnered with the U.S. Census Bureau to conduct the Household Pulse Survey (HPS). This report describes trends in the percentage of adults with symptoms of an anxiety disorder or a depressive disorder and those who sought mental health services. During August 19, 2020-February 1, 2021, the percentage of adults with symptoms of an anxiety or a depressive disorder during the past 7 days increased significantly (from 36.4% to 41.5%), as did the percentage reporting that they needed but did not receive mental health counseling or therapy during the past 4 weeks (from 9.2% to 11.7%). Increases were largest among adults aged 18-29 years and among those with less than a high school education. HPS data can be used in near real time to evaluate the impact of strategies that address mental health status and care of adults during the COVID-19 pandemic and to guide interventions for groups that are disproportionately affected.

Entities:  

Mesh:

Year:  2021        PMID: 33793459      PMCID: PMC8022876          DOI: 10.15585/mmwr.mm7013e2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


The spread of disease and increase in deaths during large outbreaks of transmissible diseases is often associated with fear and grief (). Social restrictions, limits on operating nonessential businesses, and other measures to reduce pandemic-related mortality and morbidity can lead to isolation and unemployment or underemployment, further increasing the risk for mental health problems (). To rapidly monitor changes in mental health status and access to care during the COVID-19 pandemic, CDC partnered with the U.S. Census Bureau to conduct the Household Pulse Survey (HPS). This report describes trends in the percentage of adults with symptoms of an anxiety disorder or a depressive disorder and those who sought mental health services. During August 19, 2020–February 1, 2021, the percentage of adults with symptoms of an anxiety or a depressive disorder during the past 7 days increased significantly (from 36.4% to 41.5%), as did the percentage reporting that they needed but did not receive mental health counseling or therapy during the past 4 weeks (from 9.2% to 11.7%). Increases were largest among adults aged 18–29 years and among those with less than a high school education. HPS data can be used in near real time to evaluate the impact of strategies that address mental health status and care of adults during the COVID-19 pandemic and to guide interventions for groups that are disproportionately affected. HPS is a rapid-response online survey using a probability-based sample design to measure the social and economic impact of the COVID-19 pandemic on U.S. households (). This experimental data product* was developed by the U.S. Census Bureau in partnership with CDC’s National Center for Health Statistics (NCHS) and several other federal statistical agencies. The sample is drawn from the U.S. Census Bureau’s Master Address File. E-mail addresses and mobile telephone numbers associated with randomly selected housing units are used to invite participants. Analytic files include self-reported data from one adult aged ≥18 years at each address. Data collection began on April 23, 2020, and is ongoing (phase 1 = April 23–July 21, 2020; phase 2 = August 19–October 26, 2020; phase 3 = October 28, 2020–present, with a break during December 22, 2020–January 5, 2021). HPS response rates averaged 2.9%, 9.3%, and 6.5% during phase 1, phase 2, and phase 3 (through February 1, 2021), respectively. Questions on mental health symptoms were based on the validated four-item Patient Health Questionnaire (PHQ-4) for depression and anxiety and included how often, during the past 7 days, respondents had been bothered by 1) feeling nervous, anxious, or on edge; 2) not being able to stop or control worrying; 3) having little interest or pleasure in doing things; and 4) feeling down, depressed, or hopeless. Adults who had symptoms that generally occurred more than one half of the days or nearly every day were classified as having symptoms, consistent with published scoring recommendations (). Questions about mental health care use included whether, during the past 4 weeks, respondents had 1) taken prescription medication for their mental health, 2) received counseling or therapy from a mental health professional, or 3) needed but did not receive counseling or therapy from a mental health professional (i.e., had an unmet mental health need). Because of methodological differences between phases 1 and 2, trend analyses were limited to phases 2 and 3. Estimates** are presented for each 2-week data collection period for August 19, 2020–February 1, 2021 (unweighted sample size = 431,656 for phase 2 and 358,977 for phase 3, total = 790,633). Trends were assessed using joinpoint regression. In addition, changes in estimates of symptoms of an anxiety or a depressive disorder and the two mental health care measures were compared between August 19–31, 2020, and January 20–February 1, 2021, according to selected respondent characteristics. SAS-callable SUDAAN (version 11.0; RTI International) was used to conduct these analyses. Estimates were weighted to adjust for nonresponse and number of adults in the household and to match U.S. Census Bureau estimates of the population by age, sex, race/ethnicity, and educational attainment. During August 19–31, 2020, through December 9–21, 2020, significant increases were observed in the percentages of adults who reported experiencing symptoms of an anxiety disorder (from 31.4% to 36.9%), depressive disorder (from 24.5% to 30.2%), and at least one of these disorders (from 36.4% to 42.4%) (Figure 1). Estimates for all three mental health indicators through January 2021 were similar to those in December 2020.
FIGURE 1

Percentage of adults aged ≥18 years with symptoms of anxiety disorder, depressive disorder, or anxiety or depressive disorder during past 7 days, by data collection period — Household Pulse Survey, United States, August 19, 2020–February 1, 2021*

* Household Pulse Survey data collection included a 1-day break between the conclusion of one data collection period and the start of the next, as well as a 2-week break during December 22, 2020–January 5, 2021.

Percentage of adults aged ≥18 years with symptoms of anxiety disorder, depressive disorder, or anxiety or depressive disorder during past 7 days, by data collection period — Household Pulse Survey, United States, August 19, 2020–February 1, 2021* * Household Pulse Survey data collection included a 1-day break between the conclusion of one data collection period and the start of the next, as well as a 2-week break during December 22, 2020–January 5, 2021. During August 19–31, 2020, through November 25–December 7, 2020, a significant increase was observed in the percentage of adults who reported taking prescription medication or receiving counseling for their mental health (from 22.4% to 25.0%) (Figure 2). Similarly, during August 19–31, 2020, through December 9–21, 2020, a significant increase was observed in the percentage of adults who reported needing but not receiving counseling or therapy for their mental health (from 9.2% to 12.4%). Estimates through January 2021 were similar to those in December 2020.
FIGURE 2

Percentage of adults aged ≥18 years who took prescription medication for mental health or received counseling or therapy during past 4 weeks and percentage who needed but did not receive counseling or therapy during past 4 weeks, by data collection period — Household Pulse Survey, United States, August 19, 2020–February 1, 2021*

* Household Pulse Survey data collection included a 1-day break between the conclusion of one data collection period and the start of the next, as well as a 2-week break during December 22, 2020–January 5, 2021.

Percentage of adults aged ≥18 years who took prescription medication for mental health or received counseling or therapy during past 4 weeks and percentage who needed but did not receive counseling or therapy during past 4 weeks, by data collection period — Household Pulse Survey, United States, August 19, 2020–February 1, 2021* * Household Pulse Survey data collection included a 1-day break between the conclusion of one data collection period and the start of the next, as well as a 2-week break during December 22, 2020–January 5, 2021. During August 19–31, 2020, through January 20–February 1, 2021, symptoms of an anxiety or a depressive disorder increased significantly from 36.4% to 41.5% (Table). Significant increases were observed for all demographic subgroups presented, except adults aged ≥80 years and non-Hispanic adults reporting races other than White, Black, or Asian. The largest increases (8.0 and 7.8 percentage points) were among those aged 18–29 years and those with less than a high school education, respectively. During this time, mental health care treatment increased significantly from 22.4% to 24.8%. Significant increases were observed for adults aged 18–29, 30–39, and 60–69 years; men and women; non-Hispanic White and non-Hispanic Black adults; adults with at least a high school education; and adults who had not experienced symptoms of an anxiety or a depressive disorder during the past 7 days.
TABLE

Weighted* percentage of adults aged ≥18 years with symptoms of anxiety or depressive disorder during past 7 days, percentage who took prescription medication for mental health or received counseling or therapy during past 4 weeks, and percentage who needed but did not receive counseling or therapy during past 4 weeks, by selected characteristics — Household Pulse Survey, United States, August 19, 2020–February 1, 2021

Characteristic% (95% CI)
Symptoms of anxiety or depressive disorder during past 7 days
Took prescription medication for mental health or received counseling or therapy during past 4 weeks
Needed but did not receive counseling or therapy during past 4 weeks
Aug 19–31, 2020Jan 20–Feb 1, 2021Aug 19–31, 2020Jan 20–Feb 1, 2021Aug 19–31, 2020Jan 20–Feb 1, 2021
Total
36.4 (35.9–36.9)
41.5 (40.7–42.2)
22.4 (22.0–22.9)
24.8 (24.2–25.4)
9.2 (8.8–9.6)
11.7 (11.1–12.2)
Age group, yrs
18–29
49.0 (47.5–50.5)
57.0 (54.2–59.8)
23.3 (21.5–25.2)
26.9 (24.9–29.0)
15.6 (14.5–16.7)
22.8 (20.3–25.4)
30–39
42.5 (40.8–44.1)
45.9 (44.5–47.3)
23.1 (22.1–24.1)
27.1 (25.8–28.4)
12.9 (11.9–13.9)
16.1 (14.8–17.5)
40–49
37.6 (36.3–39.0)
41.1 (38.9–43.2)
23.6 (22.8–24.5)
25.0 (23.7–26.3)
10.0 (9.3–10.7)
11.0 (10.0–11.9)
50–59
34.9 (33.6–36.3)
41.2 (39.8–42.6)
23.9 (22.8–25.1)
25.4 (24.0–26.9)
7.7 (6.9–8.5)
9.5 (8.6–10.4)
60–69
29.3 (28.0–30.6)
33.4 (31.6–35.4)
21.2 (20.2–22.2)
23.3 (22.0–24.6)
5.3 (4.8–5.9)
5.4 (4.8–6.0)
70–79
23.2 (21.6–25.0)
26.3 (24.6–28.0)
19.6 (18.1–21.1)
19.8 (18.3–21.3)
2.9 (2.2–3.6)
3.1 (2.4–3.9)
≥80
19.4 (16.3–22.9)
22.5 (18.5–27.0)
14.8 (12.0–17.9)
17.3 (14.1–21.0)
1.4 (0.9–2.0)
2.3 (1.3–3.7)
Sex
Male
31.8 (30.8–32.8)
38.0 (36.9–39.1)
16.3 (15.6–17.1)
19.1 (18.1–20.1)
6.8 (6.2–7.3)
9.1 (8.3–9.8)
Female
40.7 (39.9–41.5)
44.8 (43.8–45.8)
28.0 (27.3–28.7)
30.0 (29.3–30.7)
11.4 (10.9–11.9)
14.1 (13.4–14.8)
Race/Ethnicity
Hispanic or Latino
40.2 (38.0–42.3)
47.1 (44.7–49.4)
17.2 (15.8–18.6)
19.5 (17.3–21.9)
9.6 (8.6–10.6)
12.8 (10.9–14.9)
White, non-Hispanic
35.4 (34.8–35.9)
39.8 (38.9–40.7)
25.6 (25.0–26.1)
28.1 (27.3–28.8)
9.1 (8.7–9.5)
11.7 (11.2–12.1)
Black, non-Hispanic
37.7 (35.7–39.8)
44.5 (41.6–47.5)
15.6 (14.2–17.1)
18.7 (16.7–20.8)
9.3 (8.3–10.3)
12.2 (10.4–14.1)
Asian, non-Hispanic
30.5 (28.2–32.8)
37.4 (33.4–41.5)
11.1 (9.7–12.5)
12.9 (10.7–15.4)
4.8 (3.9–5.8)
5.8 (4.5–7.3)
Other/Multiple races, non-Hispanic
43.1 (40.2–46.1)
44.8 (41.0–48.6)
25.0 (22.3–27.9)
23.8 (20.9–26.9)
14.2 (12.1–16.4)
13.8 (11.4–16.5)
Education level
Less than high school diploma
41.8 (38.4–45.2)
49.6 (45.7–53.5)
20.0 (17.3–22.9)
20.6 (17.5–24.0)
7.0 (5.4–8.8)
11.3 (8.8–14.2)
High school diploma or GED certificate
36.3 (35.0–37.7)
41.1 (39.3–42.9)
20.1 (19.1–21.2)
22.2 (20.9–23.4)
7.0 (6.3–7.8)
8.7 (7.4–10.2)
Some college or associate’s degree
39.4 (38.5–40.3)
46.4 (45.2–47.6)
23.5 (22.7–24.4)
27.7 (26.8–28.7)
11.2 (10.6–11.9)
14.9 (13.9–15.9)
Bachelor’s degree or higher
32.4 (31.7–33.0)
35.5 (34.7–36.3)
24.0 (23.4–24.6)
25.4 (24.6–26.1)
9.7 (9.2–10.1)
11.4 (10.9–12.0)
Symptoms of anxiety or depressive disorder during past 7 days
Did not experience symptoms
NA
NA
13.9 (13.4–14.4)
15.6 (14.9–16.4)
2.4 (2.2–2.7)
3.1 (2.8–3.5)
Experienced symptomsNANA37.5 (36.5–38.5)37.7 (36.6–38.8)21.0 (20.2–21.8)23.8 (22.8–24.9)

Abbreviations: CI = confidence interval; GED = general educational development; NA = not applicable.

* Estimates were weighted to adjust for nonresponse and number of adults in the household and to match U.S. Census Bureau estimates of the population by age, sex, race/ethnicity, and educational attainment.

† Significant difference between percentages at two time points (August 19–31, 2020, versus January 20–February 1, 2021) based on two-sided significance tests at the 0.05 level.

Abbreviations: CI = confidence interval; GED = general educational development; NA = not applicable. * Estimates were weighted to adjust for nonresponse and number of adults in the household and to match U.S. Census Bureau estimates of the population by age, sex, race/ethnicity, and educational attainment. † Significant difference between percentages at two time points (August 19–31, 2020, versus January 20–February 1, 2021) based on two-sided significance tests at the 0.05 level. Unmet mental health needs also increased significantly from 9.2% to 11.7%. Subgroups with significant increases included adults aged 18–29, 30–39, and 50–59 years; men and women; Hispanic, non-Hispanic White, and non-Hispanic Black adults; adults at all education levels; and adults regardless of whether they experienced symptoms of an anxiety or a depressive disorder or both during the past 7 days. The largest increases in unmet mental health needs (7.2 percentage points and 4.3 percentage points) were among adults aged 18–29 years and those with less than a high school education, respectively. During January 20, 2021–February 1, 2021, 23.8% of persons with symptoms of an anxiety or a depressive disorder had unmet mental health needs, and this percentage increased by 2.8 percentage points from August 2020 to February 2021.

Discussion

The percentage of adults who had symptoms of an anxiety or a depressive disorder during the past 7 days and those with unmet mental health needs during the past 4 weeks increased significantly from August 2020 to February 2021, with the largest increases among those aged 18–29 years and those with less than a high school education. During January 20, 2021–February 1, 2021, more than two in five adults aged ≥18 years experienced symptoms of an anxiety or a depressive disorder during the past 7 days. One in four adults who experienced these symptoms reported that they needed but did not receive counseling or therapy for their mental health. These findings are consistent with results from surveys conducted early in the COVID-19 pandemic (March–June 2020) that showed an increased prevalence of mental health symptoms, especially among young adults (–). The more recent results indicate an increasing prevalence over time later in 2020, which remained increased in early 2021. The trends in symptoms of an anxiety or a depressive disorder from HPS have been shown to be consistent with trends in the weekly number of reported COVID-19 cases, and it has been theorized that increases in these mental health indicators correspond with pandemic trends (). The findings in this report are subject to at least four limitations. First, these data are based on self-report and were not confirmed by health professionals. Questions about mental health symptoms might be predictive of but do not necessarily reflect a clinical diagnosis. In addition, the predictive validity of the scales used in this report have not been confirmed when adapted from a 2-week to a 1-week time frame. Second, HPS did not assess the cause of these symptoms; therefore, a direct association with COVID-19 events could not be determined with certainty. Third, changes in mental health symptoms from the summer to the winter months might reflect symptoms associated with seasonal affective disorder (). However, data from the 2019 National Health Interview Survey (NHIS), measured using the unmodified PHQ-4, did not demonstrate statistically significant changes from August to December 2019 for symptoms of an anxiety disorder (8.1% to 8.6%); a depressive disorder (7.0% to 6.7%); or an anxiety disorder, a depressive disorder, or both (11.0% to 11.3%) (). Finally, these estimates are intended to represent all adults aged ≥18 years living in housing units in the United States. However, representativeness might be limited by the indirect exclusion of persons without Internet access and by low response rates. Some households were not eligible to participate because the U.S. Census Bureau was unable to match a mobile telephone number or e-mail address. The sampling weights that were applied to all analyses were likely to have reduced some of the potential bias. Nevertheless, these data might not fully meet the U.S. Census Bureau’s quality standards and as such, the bureau labeled these data as experimental. Despite these limitations, the survey’s timeliness and relevance are strengths of HPS. The U.S. Census Bureau releases data tables to the public 9 days after the close of each data collection period. Simultaneously, NCHS updates online visualizations of trends in key health indicators.*** Several measures have been initiated to address increased mental health risks associated with COVID-19, and a previous report outlines additional strategies, including expanded use of telehealth, to address mental health conditions during the pandemic (). Continued near real-time monitoring of mental health trends by demographic characteristics is critical during the COVID-19 pandemic. These trends might be used to evaluate the impact of strategies that address mental health status and care of adults during the pandemic and to guide interventions for groups that are disproportionately affected.

What is already known about this topic?

Large disease outbreaks have been associated with mental health problems.

What is added by this report?

During August 2020–February 2021, the percentage of adults with recent symptoms of an anxiety or a depressive disorder increased from 36.4% to 41.5%, and the percentage of those reporting an unmet mental health care need increased from 9.2% to 11.7%. Increases were largest among adults aged 18–29 years and those with less than a high school education.

What are the implications for public health practice?

Trends in mental health can be used to evaluate the impact of strategies addressing adult mental health status and care during the pandemic and to guide interventions for disproportionately affected groups.
  6 in total

1.  Unemployment Insurance, Health-Related Social Needs, Health Care Access, and Mental Health During the COVID-19 Pandemic.

Authors:  Seth A Berkowitz; Sanjay Basu
Journal:  JAMA Intern Med       Date:  2021-05-01       Impact factor: 21.873

2.  Seasonal variation in symptoms of depression: A Canadian population based study.

Authors:  Aysha Lukmanji; Jeanne V A Williams; Andrew G M Bulloch; Asmita Bhattarai; Scott B Patten
Journal:  J Affect Disord       Date:  2019-05-23       Impact factor: 4.839

3.  An ultra-brief screening scale for anxiety and depression: the PHQ-4.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Bernd Löwe
Journal:  Psychosomatics       Date:  2009 Nov-Dec       Impact factor: 2.386

4.  The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health: Current Risks and Recommended Actions.

Authors:  Doron Amsalem; Lisa B Dixon; Yuval Neria
Journal:  JAMA Psychiatry       Date:  2021-01-01       Impact factor: 21.596

5.  Racial and Ethnic Disparities in the Prevalence of Stress and Worry, Mental Health Conditions, and Increased Substance Use Among Adults During the COVID-19 Pandemic - United States, April and May 2020.

Authors:  Lela R McKnight-Eily; Catherine A Okoro; Tara W Strine; Jorge Verlenden; NaTasha D Hollis; Rashid Njai; Elizabeth W Mitchell; Amy Board; Richard Puddy; Craig Thomas
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-05       Impact factor: 17.586

6.  Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020.

Authors:  Mark É Czeisler; Rashon I Lane; Emiko Petrosky; Joshua F Wiley; Aleta Christensen; Rashid Njai; Matthew D Weaver; Rebecca Robbins; Elise R Facer-Childs; Laura K Barger; Charles A Czeisler; Mark E Howard; Shantha M W Rajaratnam
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-08-14       Impact factor: 17.586

  6 in total
  72 in total

1.  Mental Health Surveillance Among Children - United States, 2013-2019.

Authors:  Rebecca H Bitsko; Angelika H Claussen; Jesse Lichstein; Lindsey I Black; Sherry Everett Jones; Melissa L Danielson; Jennifer M Hoenig; Shane P Davis Jack; Debra J Brody; Shiromani Gyawali; Matthew J Maenner; Margaret Warner; Kristin M Holland; Ruth Perou; Alex E Crosby; Stephen J Blumberg; Shelli Avenevoli; Jennifer W Kaminski; Reem M Ghandour
Journal:  MMWR Suppl       Date:  2022-02-25

2.  Associations of Anxiety during the COVID-19 Pandemic with Patient Characteristics and Behaviors in CKD Patients: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Kirsten S Dorans; Julie A Wright Nunes; Douglas E Schaubel; Daohang Sha; Sarah J Schrauben; Robert G Nelson; Panduranga S Rao; Debbie L Cohen; Lawrence J Appel; James P Lash; Mahboob Rahman; Harold I Feldman
Journal:  Kidney360       Date:  2022-05-24

3.  Catalpol Exerts Antidepressant-Like Effects by Enhancing Anti-oxidation and Neurotrophy and Inhibiting Neuroinflammation via Activation of HO-1.

Authors:  Xiaohui Wu; Chen Liu; Junming Wang; Yuechen Guan; Lingling Song; Rongxing Chen; Mingzhu Gong
Journal:  Neurochem Res       Date:  2022-06-06       Impact factor: 4.414

4.  Psychological wellbeing in the English population during the COVID-19 pandemic: A series of cross-sectional surveys.

Authors:  Louise E Smith; Richard Amlȏt; Nicola T Fear; Susan Michie; G James Rubin; Henry W W Potts
Journal:  J Psychiatr Res       Date:  2022-06-29       Impact factor: 5.250

5.  Implementing Evidence-Based Preventive Interventions During a Pandemic.

Authors:  Pamela R Buckley; Dan Edwards; Amanda Ladika; Christine M Steeger; Karl G Hill
Journal:  Glob Implement Res Appl       Date:  2022-07-05

6.  Depressive and anxious symptoms among young adults in the COVID-19 pandemic: Results from monitoring the future.

Authors:  Noah T Kreski; Katherine M Keyes; Michael J Parks; Megan E Patrick
Journal:  Depress Anxiety       Date:  2022-05-27       Impact factor: 8.128

7.  National Health Interview Survey, COVID-19, and Online Data Collection Platforms: Adaptations, Tradeoffs, and New Directions.

Authors:  Stephen J Blumberg; Jennifer D Parker; Brian C Moyer
Journal:  Am J Public Health       Date:  2021-12       Impact factor: 9.308

8.  Uncovering survivorship bias in longitudinal mental health surveys during the COVID-19 pandemic.

Authors:  Mark É Czeisler; Joshua F Wiley; Charles A Czeisler; Shantha M W Rajaratnam; Mark E Howard
Journal:  Epidemiol Psychiatr Sci       Date:  2021-05-26       Impact factor: 6.892

9.  Mental Health Among Parents of Children Aged <18 Years and Unpaid Caregivers of Adults During the COVID-19 Pandemic - United States, December 2020 and February-⁠March 2021.

Authors:  Mark É Czeisler; Elizabeth A Rohan; Stephanie Melillo; Jennifer L Matjasko; Lara DePadilla; Chirag G Patel; Matthew D Weaver; Alexandra Drane; Sarah S Winnay; Emily R Capodilupo; Rebecca Robbins; Joshua F Wiley; Elise R Facer-Childs; Laura K Barger; Charles A Czeisler; Mark E Howard; Shantha M W Rajaratnam
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-06-18       Impact factor: 17.586

10.  Stress, social support and their relationship to depression and anxiety among Latina immigrant women.

Authors:  Daron Ryan; Stephanie N Tornberg-Belanger; Georgina Perez; Serena Maurer; Cynthia Price; Deepa Rao; Kwun C G Chan; India J Ornelas
Journal:  J Psychosom Res       Date:  2021-07-30       Impact factor: 4.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.